Peroxisome proliferator-activated receptor agonists prevent 25-OH-cholesterol induced c-jun activation and cell death

BMC Pharmacology

Volumn 1, Issue , 2001, Pages

  Chang, Jason Y ^a,b   Liu, Ling Zhi ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

15 DEOXY DELTA12,14 PROSTAGLANDIN J2; 25 HYDROXYCHOLESTEROL; CELL NUCLEUS RECEPTOR; IBUPROFEN; INDOMETACIN; MITOGEN ACTIVATED PROTEIN KINASE; OXYSTEROL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PIRINIXIC ACID; PROTEIN C JUN; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; ATHEROGENESIS; CELL DEATH; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVITY; INHIBITION KINETICS; MICROGLIA; MOLECULAR MECHANICS; MOUSE; NONHUMAN; SENSITIVITY ANALYSIS; TIME; WESTERN BLOTTING;

EID: 2642559661     PISSN: 14712210     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-2210-1-10     Document Type: Article

References (66)

1. Steinberg D: Lewis A. Conner Memorial Lecture: Oxidative modification of LDL and atherogenesis. Circulation 1997, 95:1062-1071
2. Hubbard RW, Ono Y, Sanchez A: Atherogenic effect of oxidized products of cholesterol. Prog. Fd. Nutr. Sci 1989, 13:17-44
3. Imai H, Werthessen NT, LeQuesne PW, Soloway AH, Kanisawa M: Angiotoxicity of oxygenated sterols and possible precursors. Science 1980, 207:651-653
4. Schroepfer GJ Jr: Oxysterols: modulators of cholesterol metabolism and other processes. Physiol. Rev 2000, 80:361-554
5. Smith LL, Johnson BH: Biological activities of oxysterols. Free Rad. Biol. & Med 1989, 7:285-332
6. AyalaTorres S, Moller PC, Johnson BH, Thompson EB: Characteristics of 25-hydroxycholesterol-induced apoptosis in the human leukemic cell line CEM. Exp. Cell Res 1997, 235:35-47
7. Chang JY, Chavis JA, Liu L, Drew PD: Cholesterol oxides induce programmed cell death in microglial cells. Biochem. Biophys. Res. Comm 1998, 249:817-821
8. Nishio E, Watanabe Y: Oxysterols induced apoptosis in cultured smooth muscle cells through CPP32 protease activation and bcl-2 protein downregulation. Biochem. Biophys. Res. Commun 1996, 226:928-934
9. Deshmukh M, Johnson EM: Programmed cell death in neurons: Focus on the pathway of nerve growth factor deprivation-induced death of sympathetic neurons. Mol. Pharmacol 1997, 51:897-906
10. Oppenheim RW: Cell death during development of the nervous system. Annu. Rev. Neurosci 1991, 14:453-501
11. Raff MC, Barres BA, Burne JF, Coles HS, Ishizaki Y, Jacobson MD: Programmed cell death and the control of cell survival - Lessons from the nervous system. Science 1993, 262:695-700
12. Force T, Bonventre JV: Growth factors and mitogen-activated protein kinases. Hypertension 1998, 31:152-161
13. Karin M: Mitogen-activated protein kinase cascades as regulators of stress responses. Ann. N. Y. Acad. Sci 1998, 851:139-146
14. Seger R, Krebs EG: The MAPK signaling cascade. FASEB J 1995, 9:726-735
15. Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME: Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 1995, 270:1326-1331
16. Stone AA, Chambers TC: Microtubule inhibitors elicit differential effects on MAP kinase (JNK, ERK, and p38) signaling pathways in human KB-3 carcinoma cells. Exp. Cell Res 2000, 254:110-119
17. Kusuhara M, Chait A, Cader A, Berk BC: Oxidized LDL stimulates mitogen-activated protein kinases in smooth muscle cells and macrophages. Arterioscler. Thromb. Vasc. Biol 1997, 17:141-148
18. Metzler B, Hu Y, Dietrich H, Xu Q: Increased expression and activation of stress-activated protein kinases/c-Jun NH(2)-terminal protein kinases in atherosclerotic lesions coincide with p53. Am. J. Pathol 2000, 156:1875-1886
19. Kersten S, Desvergne B, Wahli W: Roles of PPARs in health and disease. Nature 2000, 405:421-424
20. Corton JC, Anderson SP, Stauber A: Central role of peroxisome proliferator-activated receptors in the actions of peroxisome proliferators. Annu. Rev. Pharmacol. Toxicol 2000, 40:491-518
21. Bishop-Bailey D: Peroxisome proliferator-activated receptors in the cardiovascular system. Br. J. Pharmacol 2000, 129:823-834
22. Ricote M, Huang J, Fajas L, Li A, Welch J, Najib J, Witztum JL, Auwerx J, Palinski W, Glass CK: Expression of the peroxisome proliferator-activated receptor gamma (PPARgamma) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein. Proc. Natl. Acad. Sci. USA 1998, 95:7614-7619
23. Nagy L, Tontonoz P, Alvarez JG, Chen H, Evans RM: Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma. Cell 1998, 93:229-240
24. Jiang C, Ting AT, Seed B: PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature 1998, 391:82-86
25. Ricote M, Li AC, Willson TM, Kelly CJ, Glass CK: The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature 1998, 391:79-82
26. Li AC, Brown KK, Silvestre MJ, Willson TM, Palinski W, Glass CK: Peroxisome proliferator-activated receptor gamma ligands inhibit development of atherosclerosis in LDL receptor-deficient mice. J. Clin. Invest 2000, 106:523-531
27. Lehmann JM, Lenhard JM, Oliver BB, Ringold GM, Kliewer SA: Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal antiinflammatory drugs. J. Biol. Chem 1997, 272:3406-3410
28. Vatassery GT, Quach HT, Smith WE, Ungar F: Oxidation of cholesterol in synaptosomes and mitochondria isolated from rat brains. Lipids 1997, 32:879-886
29. Chang JY, Liu LZ: 25-Hydroxycholesterol causes death but does not prevent NGF-induced neurite outgrowth in PC12 cells. Neurochem. Int 1997, 31:517-523
30. Chang JY, Phelan KD, Liu LZ: Neurotoxicity of 25-OH-cholesterol on NGF-differentiated PC12 cells. Neurochem. Res 1998, 23:7-16
31. Chang JY, Phelan KD, Chavis JA: Neurotoxicity of 25-OH-cholesterol on sympathetic neurons. Brain Res. Bull 1998, 45:615-622
32. Chang JY, Liu LZ: Toxicity of cholesterol oxides on cultured neuroretinal cells. Curr. Eye Res 1998, 17:95-103
33. Chang JY, Liu LZ: Neurotoxicity of cholesterol oxides on cultured cerebellar granule cells. Neurochem. Int 1998, 32:317-323
34. Mato M, Ookawara S, Sakamoto A, Aikawa E, Ogawa T, Mitsuhashi U, Masuzawa T, Suzuki H, Honda M, Yazaki Y, et al: Involvement of specific macrophage-lineage cells surrounding arterioles in barrier and scavenger function in brain cortex. Proc. Natl. Acad. Sci. USA 1996, 93:3269-3274
35. Barron KD: The microglial cell. A historical review. J. Neurol. Sci 1995, 134:57-68
36. Delerive P, De Bosscher K, Besnard S, Vanden Berghe W, Peters JM, Gonzalez FJ, Fruchart JC, Tedgui A, Haegeman G, Staels B: Peroxisome proliferator-activated receptor alpha negatively regulates the vascular inflammatory gene response by negative crosstalk with transcription factors NF-kappaB and AP-1. J. Biol. Chem 1999, 274:32048-32054
37. Delerive P, Martin-Nizard F, Chinetti G, Trottein F, Fruchart JC, Najib J, Duriez P, Staels B: Peroxisome proliferator-activated receptor activators inhibit thrombin-induced endothelin-1 production in human vascular endothelial cells by inhibiting the activator protein-1 signaling pathway. Circ. Res 1999, 85:394-402
38. Addis PB: Occurrence of lipid oxidation products in foods. Fd. Chem. Toxic 1986, 24:1021-1030
39. Maraschiello C, Esteve E, Garcia Regueiro JA: Cholesterol oxidation in meat from chickens fed alpha-tocopherol- and betacarotene-supplemented diets with different unsaturation grades. Lipids 1998, 33:705-713
40. Smith LL, Teng JI, Lin YY, Seitz PK: Sterol metabolism-XLVII. Oxidized cholesterol esters in human tissues. J. Steroid Biochem 1981, 14:889-900
41. Krut LH, Yang JW, Schonfeld G, Ostlund RE: The effect of oxidizing cholesterol on gastrointestinal absorption, plasma clearance, tissue distribution, and processing by endothelial cells. Arterioscler. Thromb. Vasc. Biol 1997, 17:778-785
42. Lange Y, Ye J, Strebel F: Movement of 25-hydroxycholesterol from the plasma membrane to the rough endoplastic reticulum in cultured hepatoma cells. J. Lipid Res 1995, 36:1092-1097
43. Hodis HN, Crawford DW, Sevanian A: Cholesterol feeding increases plasma and aortic tissue cholesterol oxides levels in parallel: Further evidence for the role of cholesterol oxidation in atherosclerosis. Atherosclerosis 1991, 89:117-126
44. Lala DS, Syka PM, Lazarchik SB, Mangelsdorf DJ, Parker KL, Heyman RA: Activation of the orphan nuclear receptor steroidogenic factor 1 by oxysterols. Proc Natl Acad Sci USA 1997, 94:4895-4900
45. Janowski BA, Willy PJ, Devi TR, Falck JR, Mangelsdorf DJ: An oxysterol signalling pathway mediated by the nuclear receptor LXR. Nature 1996, 383:728-731
46. Lehmann JM, Kliewer SA, Moore LB, Smith-Oliver TA, Oliver BB, Su JL, Sundseth SS, Winegar DA, Blanchard DE, Spencer TA, et al: Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway. J. Biol. Chem 1977, 272:3137-3140
47. Brown MS, Goldstein JL: Suppression of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and inhibition of growth of human fibroblasts by 7-ketocholesterol. J. Biol. Chem 1974, 249:7306-7314
48. Taylor FR, Saucier SE, Shown EP, Parish EJ, Kandutsch AA: Correlation between oxysterol binding to a cytosolic binding protein and potency in the repression of hydroxymethylglutaryl coenzyme A reductase. J. Biol. Chem 1984, 259:12382-12387
49. Taylor F: Correlation among oxysterol potencies in the regulation of the degradation of 3-hydroxy-3-methylglutaryl CoA reductase, the depression of 3-hydroxy-3-methylglutaryl CoA synthase and affinities for the oxysterol receptor. Biochem. Biophys. Res. Comm 1992, 186:182-189
50. Rusinol AE, Yang L, Thewke D, Panini SR, Kramer MF, Sinensky MS: Isolation of a somatic cell mutant resistant to the induction of apoptosis by oxidized low density lipoprotein. J. Biol. Chem 2000, 275:7296-7303
51. Thompson EB, Ayala-Torres S: Oxysterols and apoptosis: evidence for gene regulation outside the cholesterol pathway. Crit. Rev. Biochem. Mol. Biol 1999, 34:25-32
52. Schaeffer HJ, Weber MJ: Mitogen-activated protein kinases: specific messages from ubiquitous messengers. Mol. Cell. Biol 1999, 19:2435-2444
53. Zhu Y, Lin JH, Liao HL, Friedli O Jr, Verna L, Marten NW, Straus DS, Stemerman MB: LDL induces transcription factor activator protein-1 in human endothelial cells. Arterioscler. Thromb. Vasc. Biol 1998, 18:473-480
54. Hanley K, Ng DC, He SS, Lau P, Min K, Elias PM, Bikle DD, Mangelsdorf DJ, Williams ML, Feingold KR: Oxysterols induce differentiation in human keratinocytes and increase Ap-1-dependent involucrin transcription. J. Invest. Dermatol 2000, 114:545-353
55. Schmidt A, Vogel R, Holloway MK, Rutledge SJ, Friedman O, Yang Z, Rodan GA, Friedman E: Transcription control and neuronal differentiation by agents that activate the LXR nuclear receptor family. Mol. Cell. Endocrinol 1999, 155:51-60
56. Bernardo A, Levi G, Minghetti L: Role of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma) and its natural ligand 15-deoxy-Delta12, 14-prostaglandin J2 in the regulation of microglial functions. Eur. J. Neurosci 2000, 12:2215-2223
57. Koppal T, Petrova TV, Van Eldik LJ: Cyclopentenone prostaglandin 15-deoxy-Delta(12,14)-prostaglandin J(2) acts as a general inhibitor of inflammatory responses in activated BV-2 microglial cells. Brain Res 2000, 867:115-121
58. Petrova TV, Akama KT, Van Eldik LJ: Cyclopentenone prostaglandins suppress activation of microglia: down-regulation of inducible nitric-oxide synthase by 15-deoxy-Delta12,14-prostaglandin J2. Proc. Natl. Acad. Sci. USA 1999, 96:4668-4673
59. Heneka MT, Feinstein DL, Galea E, Gleichmann M, Wullner U, Klockgether T: Peroxisome proliferator-activated receptor gamma agonists protect cerebellar granule cells from cytokine-induced apoptotic cell death by inhibition of inducible nitric oxide synthase. J. Neuroimmunol 1999, 100:156-168
60. Combs CK, Johnson DE, Karlo JC, Cannady SB, Landreth GE: Inflammatory mechanisms in Alzheimer's disease: inhibition of beta-amyloid-stimulated proinflammatory responses and neurotoxicity by PPARgamma agonists. J. Neurosci 2000, 20:558-567
61. Roberts RA, James NH, Woodyatt NJ, Macdonald N, Tugwood JD: Evidence for the suppression of apoptosis by the peroxisome proliferator activated receptor alpha (PPAR alpha). Carcinogenesis 1998, 19:43-48
62. Corradin SB, Mauel J, Donini SD, Quattrocchi E, Ricciardi-Castagnoli P: Inducible nitric oxide synthase activity of cloned murine microglial cells. Glia 1993, 7:255-262
63. Badie B, Schartner J, Vorpahl J, Preston K: Interferon-gamma induces apoptosis and augments the expression of Fas and Fas ligand by microglia in vitro. Exp. Neurol 2000, 162:290-296
64. Barger SW, Harmon AD: Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E. Nature 1997, 388:878-881
65. Meda L, Cassatella MA, Szendrei GI, Otvos L Jr, Baron P, Villalba M, Ferrari D, Rossi F: Activation of microglial cells by beta-amyloid protein and interferon-gamma. Nature 1995, 374:647-650
66. Balazs R, Jorgensen OS, Hack N: N-Methyl-D-Aspartate promotes the survival of cerebellar granule cells in culture. Neuroscience 1988, 27:437-451